• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利的乳房X光筛查:2005年调查及2006年初步数据。

Mammography screening in Italy: 2005 survey and 2006 preliminary data.

作者信息

Giorgi Daniela, Giordano Livia, Ventura Leonardo, Frigerio Alfonso, Paci Eugenio, Zappa Marco

机构信息

UO Epidemiologia, ASL 2 Lucca, Istituto Tumori Toscano.

出版信息

Epidemiol Prev. 2008 Mar-Apr;32(2 Suppl 1):7-22.

PMID:18770992
Abstract

Mammography screening programmes in Italy have been implemented since the early 90's. Over the last ten years, national and international institutions have strongly supported screening programme implementation with several laws. Since 2004, the Italian Ministry of Health, together with the Commission of Regions and Self-governing Provinces Health Officials, has officially entrusted the ONS (Osservatorio Nazionale Screening, National Centre for Screening Monitoring) with monitoring and promoting nationwide screening programmes. Previously, for several years, GISMa (Gruppo Italiano per lo Screening Mammografico) carried out a yearly survey to collect process indicators of mammography screening and compare them, using national and international standard values as reference. In 2006, an updated version of the operative report of process indicators was published by GISMa, and in November 2006 the updated national screening guidelines, prepared by the workgroups on oncological screening set up by the Ministry, was published. This report is an update of similar previous papers published by the ONS since 2002. Data for the survey come from several different programmes that may have changed over time, and may have different settings of organisation and management. During 2005, an increase in screening activity was recorded with the inclusion of all Northern and Central Italian Regions, and 2006 showed a further development n the Southern Regions and Islands. Only one Region is missing (Puglia), but it started its activity in 2007; so starting from 2007, all Italian Regions have implemented screening programmes. In 2006, more than 2 million women aged 50-69 years were invited to have a screening mammogram, and over 1,150,000 were screened. Theoretical extension was 76.4% in 2005 and 78.2% in 2006. This year shows an important increase in actual extension, improving from 50.3% in 2005 to 57.2% in 2006 and finally rising over the critical value of about 50% registered during the last years. An imbalance in coverage is still present when comparing Northern and Central Italy (more than 90%) to Southern Italy, which only has a 46% coverage by organised screening. The percentage of women screened during 2005 accounted for 28.6% of the national target population, and increased up to 31.8% in 2006. During the three-year period 2004-2006, participation rates were substantially stable around 55-57% for crude rate, and 59-60% for adjusted rate, respectively. A decreasing trend towards the South of Italy is evident for this parameter, too, but in 2005-2006 the Central Regions registered the highest increase in attendance: crude and adjusted participations rose from 52-54% in 2004 to 56-58% in 2005-2006. Many programmes work with low volumes of activity (below 10,000 or even 5,000 examinations per year), and no regional mean value surpassed the desirable level of at least 20,000 examinations for each programme. Referral rates of 8.3% at first screening and 4.5% at repeat screening were recorded. Direct standardised detection rate was 5.7 x 1,000 at first test and 4.6 at repeat test, while benign to malignant ratio for first and repeat screening was 0.28 and 0.21, respectively. Detection rate of invasive cancers < or =10 mm was 1.44 x 1,000 at first test and 1.58 at repeat test; the proportion of in situ carcinomas was 12.9% and 14.7% for first and repeat test, respectively. Indicators by 5-year age group confirm greater diagnostic problems at younger ages, with higher referral rates, higher frequency of surgical procedures with benign outcome (B/M ratio), and a substantially lower detection rate as compared to older age groups.

摘要

意大利自20世纪90年代初开始实施乳腺钼靶筛查项目。在过去十年中,国家和国际机构通过多项法律大力支持筛查项目的实施。自2004年起,意大利卫生部与各地区及自治省卫生官员委员会正式委托国家筛查监测中心(ONS)对全国范围内的筛查项目进行监测和推广。此前,意大利乳腺钼靶筛查小组(GISMa)多年来每年都进行一项调查,以收集乳腺钼靶筛查的过程指标,并将其与国家和国际标准值进行比较。2006年,GISMa发布了过程指标操作报告的更新版本,2006年11月,卫生部设立的肿瘤筛查工作组编写的更新后的国家筛查指南也得以发布。本报告是ONS自2002年以来发表的类似先前论文的更新。调查数据来自几个不同的项目,这些项目可能随时间发生了变化,并且组织和管理设置也可能不同。2005年,随着意大利北部和中部所有地区都纳入筛查活动,筛查活动有所增加,2006年南部地区和岛屿的筛查活动进一步发展。只有一个地区(普利亚)尚未开展筛查活动,但该地区于2007年开始了筛查工作;因此,从2007年起,意大利所有地区都实施了筛查项目。2006年,超过200万年龄在50 - 69岁的女性被邀请进行乳腺钼靶筛查,其中超过115万女性接受了筛查。2005年的理论覆盖率为76.4%,2006年为78.2%。今年实际覆盖率有了显著提高,从2005年的50.3%提高到2006年的57.2%,最终超过了过去几年记录的约50%的临界值。与意大利北部和中部(覆盖率超过90%)相比,意大利南部的覆盖率仍然存在不平衡,南部地区通过有组织筛查的覆盖率仅为46%。2005年接受筛查的女性占全国目标人群的28.6%,2006年这一比例上升至31.8%。在2004 - 2006年的三年期间,粗参与率基本稳定在55 - 57%左右,调整后参与率分别为59 - 60%。在这个参数上,意大利南部也明显呈现出下降趋势,但在2005 - 2006年,中部地区的参与率增幅最大:粗参与率和调整后参与率从2004年的52 - 54%上升至2005 - 2006年的56 - 58%。许多项目的筛查活动量较低(每年低于10000次甚至5000次检查),且没有一个地区的平均值超过每个项目至少20000次检查的理想水平。首次筛查的转诊率为8.3%,重复筛查的转诊率为4.5%。首次检测的直接标准化检出率为每1000人中有5.7例,重复检测为4.6例,首次和重复筛查的良性与恶性比例分别为0.28和0.21。首次检测时浸润性癌≤10mm的检出率为每1000人中有1.44例,重复检测为1.58例;首次和重复检测中原位癌的比例分别为12.9%和14.7%。按5岁年龄组划分的指标证实,较年轻年龄段存在更大的诊断问题,转诊率更高,良性手术结果(良性与恶性比例)的手术频率更高,与较年长年龄组相比,检出率大幅降低。

相似文献

1
Mammography screening in Italy: 2005 survey and 2006 preliminary data.意大利的乳房X光筛查:2005年调查及2006年初步数据。
Epidemiol Prev. 2008 Mar-Apr;32(2 Suppl 1):7-22.
2
Mammography screening in Italy: 2007 survey.意大利的乳房X线筛查:2007年调查
Epidemiol Prev. 2009 May-Jun;33(3 Suppl 2):13-28.
3
Mammography screening in Italy: 2009 survey.意大利的乳房X光检查筛查:2009年调查。
Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 5):9-27.
4
Mammography screening in Italy: 2008 survey.意大利的乳房X光筛查:2008年调查
Epidemiol Prev. 2010 Sep-Dec;34(5-6 Suppl 4):9-25.
5
Mammography screening in Italy: 2004 survey and 2005 preliminary data.意大利的乳房X线筛查:2004年调查及2005年初步数据。
Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):7-20.
6
[Mammography breast cancer screening in Italy: 2010 survey].[意大利的乳腺钼靶乳腺癌筛查:2010年调查]
Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):8-27.
7
Mammography screening in Italy: 2003-2004 survey.意大利的乳房X光筛查:2003 - 2004年调查
Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 3):7-16.
8
Mammographic breast cancer screening in Italy: 2011-2012 survey.意大利乳腺钼靶乳腺癌筛查:2011 - 2012年调查
Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):21-9.
9
Time trends of process and impact indicators in Italian breast screening programmes--1996-2005.1996 - 2005年意大利乳腺癌筛查项目中过程指标和影响指标的时间趋势
Epidemiol Prev. 2008 Mar-Apr;32(2 Suppl 1):23-36.
10
Time trends of process and impact indicators in Italian mammography screening programmes--1996-2004.1996 - 2004年意大利乳腺钼靶筛查项目中过程指标和影响指标的时间趋势
Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):21-32.

引用本文的文献

1
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment.西西里岛亚厘米级浸润性乳腺癌的形态学和生物分子特征:一项关于曲妥珠单抗治疗的多中心回顾性研究
Oncol Lett. 2012 Jan;3(1):141-146. doi: 10.3892/ol.2011.425. Epub 2011 Sep 20.